Market Forecast by Countries (United States, Canada), By Offering (Hardware, Software, Services), By Technology (Machine Learning, NLP, Context-aware Computing, Computer Vision) And Competitive Landscape
| Product Code: ETC4622024 | Publication Date: Jul 2023 | Updated Date: Dec 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 300 |
According to 6Wresearch internal database and industry insights, The North America Artificial Intelligence (AI) in Healthcare Market was valued at approximately USD 7.2 billion in 2025 and is projected to reach nearly USD 14.6 billion by 2032, registering a compound annual growth rate (CAGR) of 10.2 % during the forecast period (2026-2032).
Below mentioned are the evaluation of year-wise growth rate along with key drivers:
| Years | Est. Annual Growth (%) | Growth Drivers |
| 2021 | 6 | Rising adoption of AI solutions in diagnostic imaging and clinical decision support |
| 2022 | 6.5 | Increasing government investments and incentives for digital healthcare transformation |
| 2023 | 7 | Surge in demand for predictive analytics and personalized treatment plans |
| 2024 | 8 | Growing integration of AI with EHR systems and telemedicine services |
| 2025 | 9 | Expansion of AI-based healthcare applications in hospitals, clinics, and research institutions |
The North America Artificial Intelligence in Healthcare Market report thoroughly covers the market by countries, offering, and technology. The report provides an unbiased and detailed analysis of ongoing market trends, opportunities, high-growth areas, and market drivers, which would help stakeholders devise and align their market strategies according to the current and future market dynamics.
| Report Name | North America Artificial Intelligence in Healthcare Market |
| Forecast Period | 2026-2032 |
| Market Size | USD 14.6 billion by 2032 |
| CAGR | 10.2% |
| Growing Sector | Healthcare & Technology |
Numerous innovations, backed by the development of artificial intelligence (AI), are transforming healthcare across the globe, by providing tools to generate greater productivity and efficiency in managing patient care. Through adoption of advanced machine learning, natural language processing (NLP), and computer vision technologies, hospitals/clinics are taking advantage of AI-enabled diagnostic and predictive analytics solutions to improve operational efficiency and create better patient outcomes. With the backing of government programs and regulatory authorities, along with the growing volume of investment in digital healthcare infrastructure, these developments are leading to significant North America Artificial Intelligence in Healthcare Market Growth.
Below mentioned are some growth drivers and their impact on market dynamics:
| Drivers | Primary Segments Affected | Why It Matters |
| Government Support & Funding | All Sectors | Increases investments in AI-enabled healthcare infrastructure and innovation through programs like the U.S. NIH AI for Health initiative and Canada’s Pan-Canadian AI Strategy. |
| AI-Enabled Diagnostics | Hospitals & Clinics | Enhances accuracy in disease detection, improves patient care, and reduces human error. |
| Telemedicine Integration | Healthcare Providers | Boosts remote patient monitoring, virtual consultations, and real-time health analytics. |
| Big Data & Predictive Analytics | All Sectors | Supports data-driven decision-making, patient outcome prediction, and efficient resource allocation. |
| Rising Chronic Diseases | Healthcare Systems | Prompts adoption of AI for early diagnosis, personalized treatment, and healthcare cost reduction. |
North America Artificial Intelligence in Healthcare Market size is projected to grow at a CAGR of 10.2% during the forecast period (2026–2032). Growing governmental support through funding is driving the increasing adoption and implementation of Artificial Intelligence (AI) technology within hospitals, clinics and research institutions to provide AI solutions within North America. The use of AI in Medical Diagnosis aids in the accuracy of disease diagnosis while telemedicine enables the ability to provide care remotely. Both technologies provide healthcare providers with the ability to utilize big data and predictive analytics to make more informed decisions regarding patient care and provide optimal resource allocation.
Below mentioned are some major restraints and their influence on market dynamics:
| Restraints | Primary Segments Affected | What This Means |
| High Implementation Costs | Hospitals & Clinics | Significant upfront investments may restrict adoption in smaller healthcare facilities. |
| Data Privacy & Security Concerns | All Segments | Stringent regulations on patient data (HIPAA compliance) can slow AI deployment. |
| Technical Integration Challenges | Healthcare Providers | Integration of AI systems with legacy EHR and hospital systems requires high technical expertise. |
| Limited Skilled Workforce | All Sectors | Shortage of AI professionals and data scientists delays implementation and adoption |
The North America Artificial Intelligence in Healthcare Industry challenges are high costs for deploying advanced systems, difficulties integrating these systems with existing healthcare technologies, and ensuring compliance with regulations concerning patient confidentiality. Furthermore, due to the lack of trained personnel in AI and data analytics, adoption may be impeded by delays in recruitment and training, while the lack of interoperability between AI and electronic health record (EHR) solutions presents a number of operational challenges.
Some major trends contributing to the development of the North America Artificial Intelligence in Healthcare Market Growth are:
Here are some investment opportunities in the North America Artificial Intelligence in Healthcare Market:
Here are some top companies contributing to the North America Artificial Intelligence in Healthcare Market Share:
| Company Name | IBM Corporation |
|---|---|
| Established Year | 1911 |
| Headquarters | Armonk, New York, USA |
| Official Website | Click Here |
IBM offers AI-based healthcare solutions including Watson Health, focusing on diagnostics, data analytics, and clinical decision support for hospitals and research institutions.
| Company Name | Google Health (Alphabet Inc.) |
|---|---|
| Established Year | 2015 |
| Headquarters | Mountain View, California, USA |
| Official Website | Click Here |
Google Health leverages AI for predictive analytics, imaging, and personalized care, integrating machine learning and cloud solutions for healthcare providers.
| Company Name | Microsoft Corporation |
|---|---|
| Established Year | 1975 |
| Headquarters | Redmond, Washington, USA |
| Official Website | Click Here |
Microsoft provides AI-driven healthcare software, including Azure AI services for health, data management, and predictive analytics in hospitals and clinics.
| Company Name | Siemens Healthineers |
|---|---|
| Established Year | 1847 |
| Headquarters | Erlangen, Germany (North America operations) |
| Official Website | Click Here |
Siemens Healthineers delivers AI-enabled medical imaging, diagnostics, and software solutions, improving clinical outcomes and operational efficiency.
| Company Name | GE Healthcare |
|---|---|
| Established Year | 1892 |
| Headquarters | Chicago, Illinois, USA |
| Official Website | Click Here |
GE Healthcare offers AI-powered imaging, monitoring, and diagnostics solutions for hospitals and clinical applications, focusing on operational efficiency and patient care.
Various initiatives have been undertaken by the U.S. and Canadian governments to promote AI adoption in healthcare. For example, the U.S. NIH AI for Health program funds research and deployment of AI-driven diagnostic tools, while Canada’s Pan-Canadian AI Strategy supports AI-based healthcare projects and infrastructure development. These initiatives provide financial support, regulatory guidance, and technology adoption incentives, enabling healthcare providers to implement AI solutions effectively.
The future of the North America Artificial Intelligence in Healthcare Market is promising, driven by growing adoption of AI solutions, rising healthcare data volumes, and government support for digital transformation. Integration of machine learning, NLP, and computer vision technologies will enhance diagnostics, personalized treatment, and operational efficiency. Expansion of AI-enabled telemedicine, predictive analytics, and clinical decision support systems is expected to drive further growth across hospitals, clinics, and research institutions.
The report offers a comprehensive study of the following market segments and their leading categories.
According to Ritika Kalra, Senior Research Analyst, 6Wresearch, The United States dominates the North America Artificial Intelligence in Healthcare Market due to significant investments in digital health infrastructure, government initiatives like NIH AI for Health, and widespread adoption of AI technologies across hospitals and research institutions.
The software segment dominates the market, driven by AI-powered healthcare applications, analytics tools, and clinical decision support systems that enhance operational efficiency and patient outcomes.
Machine Learning leads the technology segment, supporting predictive analytics, diagnostic imaging, and personalized treatment planning across hospitals, clinics, and research organizations.
Hospitals are the largest end-users due to their need for AI solutions in diagnostics, clinical decision support, patient monitoring, and operational efficiency improvements.
The market report has been segmented and sub-segmented into the following categories:
| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 North America Artificial Intelligence in Healthcare Market Overview |
| 3.1 North America Regional Macro Economic Indicators |
| 3.2 North America Artificial Intelligence in Healthcare Market Revenues & Volume, 2022 & 2032F |
| 3.3 North America Artificial Intelligence in Healthcare Market - Industry Life Cycle |
| 3.4 North America Artificial Intelligence in Healthcare Market - Porter's Five Forces |
| 3.5 North America Artificial Intelligence in Healthcare Market Revenues & Volume Share, By Countries, 2022 & 2032F |
| 3.6 North America Artificial Intelligence in Healthcare Market Revenues & Volume Share, By Offering, 2022 & 2032F |
| 3.7 North America Artificial Intelligence in Healthcare Market Revenues & Volume Share, By Technology , 2022 & 2032F |
| 4 North America Artificial Intelligence in Healthcare Market Dynamics |
| 4.1 Impact Analysis |
| 4.2 Market Drivers |
| 4.3 Market Restraints |
| 5 North America Artificial Intelligence in Healthcare Market Trends |
| 6 North America Artificial Intelligence in Healthcare Market, 2022 - 2032 |
| 6.1 North America Artificial Intelligence in Healthcare Market, Revenues & Volume, By Offering, 2022 - 2032 |
| 6.2 North America Artificial Intelligence in Healthcare Market, Revenues & Volume, By Technology , 2022 - 2032 |
| 7 United States Artificial Intelligence in Healthcare Market, 2022 - 2032 |
| 7.1 United States Artificial Intelligence in Healthcare Market, Revenues & Volume, By Offering, 2022 - 2032 |
| 7.2 United States Artificial Intelligence in Healthcare Market, Revenues & Volume, By Technology , 2022 - 2032 |
| 8 Canada Artificial Intelligence in Healthcare Market, 2022 - 2032 |
| 8.1 Canada Artificial Intelligence in Healthcare Market, Revenues & Volume, By Offering, 2022 - 2032 |
| 8.2 Canada Artificial Intelligence in Healthcare Market, Revenues & Volume, By Technology , 2022 - 2032 |
| 9 North America Artificial Intelligence in Healthcare Market Key Performance Indicators |
| 10 North America Artificial Intelligence in Healthcare Market - Opportunity Assessment |
| 10.1 North America Artificial Intelligence in Healthcare Market Opportunity Assessment, By Countries, 2022 & 2032F |
| 10.2 North America Artificial Intelligence in Healthcare Market Opportunity Assessment, By Offering, 2022 & 2032F |
| 10.3 North America Artificial Intelligence in Healthcare Market Opportunity Assessment, By Technology , 2022 & 2032F |
| 11 North America Artificial Intelligence in Healthcare Market - Competitive Landscape |
| 11.1 North America Artificial Intelligence in Healthcare Market Revenue Share, By Companies, 2022-2032F |
| 11.2 North America Artificial Intelligence in Healthcare Market Competitive Benchmarking, By Operating and Technical Parameters |
| 12 Company Profiles |
| 13 Recommendations |
| 14 Disclaimer |